The home infusion therapy market is projected to attain notable growth by 2027 owing to technological advancements in intravenous devices. In addition, rising prevalence of chronic illnesses worldwide is likely to bolster market growth over the forecast timeline.

Home infusion therapy involves intravenous administration of drugs and medication to patients in home care settings. This form of therapy is commonly given to patients who require prolonged intravenous doses of medications as part of the treatment. It has been shown to be more cost-effective than therapy offered in hospital settings. Moreover, it is also convenient as patients have the option to receive treatment from the comfort of their own homes, which has positively influenced product uptake in recent years.

Notably, the ongoing COVID-19 pandemic has burdened the global healthcare infrastructure on account of soaring hospitalizations rates. It has also highlighted the benefits of home infusion therapy for patients suffering from chronic diseases to receive proper treatment without any exposure to the virus, especially due to frequent trips to hospitals or clinics, thereby facilitating market penetration during the pandemic.

Furthermore, industry players are adopting lucrative strategies to accommodate the surging demand for healthcare at home, which has positively impacted the overall market landscape. For instance, in September 2021, Baxter International, Inc., a leading medical products company, announced the acquisition of Hillrom, a major medical technology firm, to extend its healthcare services to alternative site, hospitals, and home settings. The deal accelerated Baxter’s expansion into connected and digital care solutions to offer patients with hospital-level care at home or in other settings.

The home infusion therapy market has been bifurcated on the basis of application, product, and region. Based on product, the market has further been classified into IV cannulas, infusion pumps, needleless connectors, and intravenous sets.

The IV cannulas sub-segment was valued at more than USD 1,646 million in 2020 and is anticipated to progress at a CAGR of around 11.2% over the analysis period. IV cannulas offer several benefits, such as oxygen delivery, administration of medication, and sampling of blood, which is likely to drive product demand over the following years.

In terms of application, the home infusion therapy market has been categorized into enteral nutrition, specialty pharmaceuticals, chemotherapy, anti-infective, hydration therapy, parenteral nutrition, and others. The hydration therapy sub-segment attained a substantial market share with a valuation of over USD 535 million in 2020 and is slated to witness sturdy growth over 2021-2027. Hydration therapy helps in migraine treatment, athletic recovery, and enhancement of skin and muscle health, which is set to propel segmental expansion.

From the regional point of view, the Latin America home infusion therapy market is speculated to gain significant traction, expanding at above 12.3% CAGR over the forecast period. Mounting prevalence of chronic diseases across countries in the LATAM region is estimated to foster regional market outlook over the study timeframe.